biotech
Amgen Sues Roche Over Anemia Drug
Filed in archive Corporate and Industrial News by ruth on November 10, 2005
BlogPicture

Amgen Inc. is suing Swiss pharma Roche Holding AG for allegedly infringing patents behind Amgen's anemia drug, Epogen. The bone of contention is that Roche's version of the anemia drug, CERA, which is already in the final stage of clinical trials, also contains recombinant erythropoietin, which forms the basis for Amgen's Epogen.

According to Amgen's press release:
Amgen alleges infringement of six U.S. patents owned by Amgen that claim erythropoietin (EPO) products and pharmaceutical compositions, and processes for making EPO. Amgen seeks a permanent injunction preventing the defendants from making, importing, using, offering for sale or selling recombinant human EPO, including pegylated EPO, in the United States.


Permalink: Amgen Sues Roche Over Anemia Drug
Tags: patent  anemia  amgen  biotech  drug  anemia+drug  amgen+sues  over+anemia 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/10990
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Amgen Sues Roche Over Anemia Drug:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 1 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!